Cardiff Oncology (CRDF) Non Operating Income (2021 - 2026)

Cardiff Oncology has reported Non Operating Income for 5 years, with the latest figure at $611000.0 in Q4 2025.

• Quarterly Non Operating Income fell 22.17% year-over-year to $611000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 3.45% YoY) and the FY2025 annual result came in at $3.1 million, down 3.45% from the prior year.
• Non Operating Income declined to $611000.0 in Q4 2025 per CRDF's latest filing, from $716000.0 in the prior quarter.
• Over five years, Non Operating Income peaked at $1.1 million in Q3 2023 and troughed at $81000.0 in Q1 2022.
• A 5-year average of $634842.1 and a median of $746000.0 in 2024 frame the typical range for Non Operating Income.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 69.2% in 2022, then jumped 923.46% in 2023.
• Over 5 years, Non Operating Income stood at $84000.0 in 2021, then jumped by 727.38% to $695000.0 in 2022, then jumped by 43.17% to $995000.0 in 2023, then slipped by 21.11% to $785000.0 in 2024, then dropped by 22.17% to $611000.0 in 2025.
• According to Business Quant data, Non Operating Income over the past three periods registered $611000.0, $716000.0, and $834000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.